Abano Healthcare Group Limited (NZX: ABA) Intention to Delist

Further to the announcement made by Abano Healthcare Group Limited on 25 November 2020 in relation to its Scheme of Arrangement with Adams NZ Bidco Limited (“Scheme”), NZX Operations (“NZXO”) advises of the intention for ABA to delist from the NZX Main Board (“NZSX”).

Subject to ABA obtaining final court orders on Thursday, 10 December 2020, the final day of trading in ABA will be Monday, 14 December 2020, with trading in ABA shares being halted and suspended at close of business. The record date for determining shareholder entitlements to participate in the Scheme is 5pm, Wednesday 16 December 2020. Subject to final NZX conditions being met, ABA ordinary shares will be delisted and will cease to be quoted from close of business on Tuesday, 22 December 2020.

See the link below for more details:

Abano Healthcare Group Limited (“ABA”) –Intention to delist

Source: Abano Healthcare Group Limited & NZX Market Operations

Comments from our readers

No comments yet

Add your comment:

Your name:
Your email:	Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Anti-spam verification:

Type the text you see in the image into the field below. You are asked to do this in order to verify that this enquiry is not being performed by an automated process.

Related News:

TruScreen Re-enters India Appinting New Distributor
April 30th Morning Report
CMC - Appointment of Director
General Capital subsidiary General Finance update
AIA - releases long-term blueprint for the future
April 29th Morning Report
RAK - FY25 Performance and Focus; Director Retirement
PEB - Medicare LCD Effective; Pacific Edge Seeks Recoverage
MEL - New CFO and Executive Changes
PFI - Upgraded FY25 Earnings Guidance